Articles
1 articles available
Darach Connolly
(DLA Piper)
,
Richard Jenkinson
(DLA Piper UK)
,
Daniel Wojtczak
(DLA Piper Belgium)
,
Alina Lacatus
(DLA Piper Romania)
June 1, 2021
Back in April 2017, The Times ran a story detailing how a drug giant had a “secret plan” to destroy a cancer medicine unless large price rises were agreed to by national purchasing authorities. A…